The Immunomodulatory Role of Microbiota in Rheumatic Heart Disease: What Do We Know and What Can We Learn from Other Rheumatic Diseases?
<p dir="ltr">Rheumatic heart disease (RHD) represents a serious cardiac sequela of acute rheumatic fever, occurring in 30–45% of patients. RHD is multifactorial, with a strong familial predisposition and known environmental risk factors that drive loss of immunological tolerance. The...
محفوظ في:
| المؤلف الرئيسي: | Amira Kohil (15257285) (author) |
|---|---|
| مؤلفون آخرون: | Wafa Abdalla (19437994) (author), Wisam N. Ibrahim (19437997) (author), Khalid M. Al-Harbi (19438000) (author), Amal Al-Haidose (19438003) (author), Maha Al-Asmakh (614593) (author), Atiyeh M. Abdallah (10742523) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review
حسب: Anwar I. Joudeh (16003142)
منشور في: (2023) -
What we do not know, hardly know, and really know about traffic safety
حسب: Leonard Evans (19773000)
منشور في: (2015) -
COVID-19 and Anemia: What Do We Know So Far?
حسب: Luai Abu-Ismail (10712857)
منشور في: (2023) -
Role of the gut microbiota in the pathogenesis of coeliac disease and potential therapeutic implications
حسب: Anthony K. Akobeng (7713470)
منشور في: (2020) -
Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
حسب: Hadi Mansour (17821430)
منشور في: (2024)